VYNE Therapeutics Inc.
VYNE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$40 | -$28 | -$23 | -$73 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $2 |
| Stock-Based Comp. | $3 | $3 | $4 | $8 |
| Change in WC | $5 | $0 | $2 | $5 |
| Other Non-Cash | -$2 | -$0 | -$13 | $2 |
| Operating Cash Flow | -$34 | -$25 | -$29 | -$56 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $5 | $16 | $0 |
| Inv. Purchases | -$61 | -$62 | $0 | $0 |
| Inv. Sales/Matur. | $84 | $0 | $0 | $1 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $23 | -$57 | $16 | $1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$36 |
| Stock Issued | $0 | $83 | $1 | $76 |
| Stock Repurch. | -$0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$0 | $0 | $0 |
| Financing Cash Flow | -$0 | $82 | $2 | $40 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$11 | -$0 | -$12 | -$16 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $31 | $31 | $43 | $58 |
| End Cash | $20 | $31 | $31 | $43 |
| Free Cash Flow | -$34 | -$25 | -$29 | -$56 |